CO2017005357A2 - Un proceso para la fabricación de idalopirdina - Google Patents

Un proceso para la fabricación de idalopirdina

Info

Publication number
CO2017005357A2
CO2017005357A2 CONC2017/0005357A CO2017005357A CO2017005357A2 CO 2017005357 A2 CO2017005357 A2 CO 2017005357A2 CO 2017005357 A CO2017005357 A CO 2017005357A CO 2017005357 A2 CO2017005357 A2 CO 2017005357A2
Authority
CO
Colombia
Prior art keywords
idalopirdine
manufacture
describes
preparation
pharmaceutically acceptable
Prior art date
Application number
CONC2017/0005357A
Other languages
English (en)
Spanish (es)
Inventor
Mikkel Fog Jacobsen
Ole Nielsen
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2015/079209 external-priority patent/WO2016091997A1/fr
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of CO2017005357A2 publication Critical patent/CO2017005357A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CONC2017/0005357A 2014-12-12 2017-05-26 Un proceso para la fabricación de idalopirdina CO2017005357A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201400721 2014-12-12
PCT/EP2015/079209 WO2016091997A1 (fr) 2014-12-12 2015-12-10 Procédé de fabrication d'idalopirdine

Publications (1)

Publication Number Publication Date
CO2017005357A2 true CO2017005357A2 (es) 2017-09-20

Family

ID=59011415

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2017/0005357A CO2017005357A2 (es) 2014-12-12 2017-05-26 Un proceso para la fabricación de idalopirdina

Country Status (13)

Country Link
EP (1) EP3230265A1 (fr)
JP (1) JP2017537128A (fr)
KR (1) KR20170093821A (fr)
CN (1) CN107001266A (fr)
AU (1) AU2015359347A1 (fr)
BR (1) BR112017012021A2 (fr)
CA (1) CA2968770A1 (fr)
CL (1) CL2017001466A1 (fr)
CO (1) CO2017005357A2 (fr)
IL (1) IL252471A0 (fr)
MA (1) MA41148A (fr)
MX (1) MX2017007510A (fr)
RU (1) RU2017120216A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10202010291VA (en) 2014-12-12 2020-11-27 Japan Tobacco Inc Dihydropyrimidin-2-one compounds and medical use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3042685A (en) * 1962-07-03 Process of making g-fluoro tryptamine
PE20081889A1 (es) * 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
TW201139370A (en) * 2009-12-23 2011-11-16 Lundbeck & Co As H Processes for the manufacture of a pharmaceutically active agent

Also Published As

Publication number Publication date
CL2017001466A1 (es) 2018-01-05
JP2017537128A (ja) 2017-12-14
CA2968770A1 (fr) 2016-06-16
AU2015359347A1 (en) 2017-06-08
IL252471A0 (en) 2017-07-31
MA41148A (fr) 2017-10-17
BR112017012021A2 (pt) 2018-03-13
CN107001266A (zh) 2017-08-01
KR20170093821A (ko) 2017-08-16
MX2017007510A (es) 2017-08-22
RU2017120216A (ru) 2019-01-15
EP3230265A1 (fr) 2017-10-18

Similar Documents

Publication Publication Date Title
IL283258A (en) Treatment of hypoparathyroidism
MX2022016566A (es) Composiciones que comprenden una caseina y metodos para producir las mismas.
CY1124521T1 (el) Σκευασματα αντισωματος anti-cd19
IL263709A (en) Methods for the manufacture of cannabinoid prodrugs, pharmaceutical formulations and their use
CU20160185A7 (es) Compuestos de heteroarilo para la inhibición de cinasa
TWD187539S (zh) 鞋之部分
TWD187540S (zh) 鞋之部分
HUE062136T2 (hu) Eljárás hõre lágyuló kopásálló fólia elõállítására
LT3429571T (lt) Sd1 inhibitorių deriniai, skirti neoplastinių ligų gydymui
PT3481846T (pt) 24-hidroxiesteroides 11-substituídos para utilização no tratamento de afeções relacionadas com nmda
TWD173737S (zh) 肌肉鍛鍊機器
TWD173398S (zh) 瓶子之部分
EA201790627A1 (ru) СТИМУЛЯТОРЫ рГЦ
GT201700058A (es) Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos
CL2016002338A1 (es) Uso de un compuesto que es ácido r-2-4-2-etoxi-3-4-trifluorometilfenoxipropil-tio-2-metilfenoxi acético, para el tratamiento de una enfermedad colestásica intrahepática .
EP3556345A4 (fr) Comprimé à désintégration orale comprenant un composé de carbamate
AR101368A1 (es) Forma cristalina de sofosbuvir y proceso para su preparación
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
ECSP16086196A (es) Sales farmacéuticamente aceptables de enantiomeros de pirlindole para uso en medicina
MX2018012900A (es) Uso de beta-agonistas del receptor de la hormona tiroidea.
CO2017005357A2 (es) Un proceso para la fabricación de idalopirdina
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
EA201700060A1 (ru) Терапевтическое средство для кератоконъюнктивальных расстройств
HUP1600415A2 (en) Pimavanserin salts for the manufacture of pharmaceutical formulations
LT3148588T (lt) N,n-bis-2-merkaptoetilizoftalamidas, skirtas parkinsono ligos gydymui